Changes in the cis-trans isomer selectivity of a reversed-phase liquid chromatography column during use with acidic mobile phase conditions

被引:2
作者
Dahlseid, Tina [1 ]
Florea, Alexandru [1 ]
Schulte, Grace [1 ]
Cash, Kathryn [1 ]
Xu, Xuejun [2 ]
Tattersall, Peter [2 ]
Wang, Qinggang [2 ]
Stoll, Dwight [1 ]
机构
[1] Gustavus Adolphus Coll, Dept Chem, 800W Coll Ave, St Peter, MN 56082 USA
[2] Bristol Myers Squibb, Chem Proc Dev, 1 Squibb Dr, New Brunswick, NJ 08903 USA
关键词
Hydrophobic Subtraction Model; Cis -Trans Isomer Selectivity; Pharmaceuticals; Column Aging; Selectivity Models; RETENTION DATA; BAND PROFILES; REPRODUCIBILITY; REPEATABILITY;
D O I
10.1016/j.chroma.2023.464371
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Reversed-phase liquid chromatography (RPLC) is the analytical tool of choice for monitoring process-related organic impurities and degradants in pharmaceutical materials. Its popularity is due to its general ease-of-use, high performance, and reproducibility in most cases, all of which have improved as the technique has matured over the past few decades. Nevertheless, in our work we still occasionally observe situations where RPLC methods are not as robust as we would like them to be in practice due to variations in stationary phase chemistry between manufactured batches (i.e., lot-to-lot variability), and changes in stationary phase chemistry over time. Over the last three decades several models of RPLC selectivity have been developed and used to quantify and rationalize the effects of numerous parameters (e.g., effect of bonded phase density) on separation selectivity. The Hydrophobic Subtraction Model (HSM) of RPLC selectivity has been used extensively for these purposes; currently the publicly available database of column parameters contains data for 750 columns. In this work we explored the possibility that the HSM could be used to better understand the chemical basis of observed differences in stationary phase selectivity when they occur - for example, lot-to-lot variations or changes in selectivity during column use. We focused our attention on differences and changes in the observed selectivity for a pair of cis-trans isomers of a pharmaceutical intermediate. Although this is admittedly a challenging case, we find that the observed changes in selectivity are not strongly correlated with HSM column parameters, suggesting that there is a gap in the information provided by the HSM with respect to cis-trans isomer selectivity specifically. Further work with additional probe molecules showed that larger changes in cis-trans isomer selectivity were observed for pairs of molecules with greater molecular complexity, compared to the selectivity changes observed for simpler molecules. These results do not provide definitive answers to questions about the chemical basis of changes in stationary phase chemistry that lead to observed differences in cis-trans isomer selectivity. However, the results do provide important insights about the critical importance of molecular complexity when choosing probe compounds and indicate opportunities to develop improved selectivity models with increased sensitivity for cis-trans isomer selectivity.
引用
收藏
页数:10
相关论文
共 25 条
[1]  
[Anonymous], 2006, Impurities in new drug substances Q3A (R2)
[2]  
Borman P., 2010, pharmaceut, Technol., V34, P141
[3]   Contributions to reversed-phase column selectivity. I. Steric interaction [J].
Carr, P. W. ;
Dolan, J. W. ;
Neue, U. D. ;
Snyder, L. R. .
JOURNAL OF CHROMATOGRAPHY A, 2011, 1218 (13) :1724-1742
[4]  
Clarke A., 2020, Specification of Drug Substances and Products: Development and Validation of Analytical Methods, V2, P247
[5]   Recent Advances in Chromatography for Pharmaceutical Analysis [J].
D'Atri, Valentina ;
Fekete, Szabolcs ;
Clarke, Adrian ;
Veuthey, Jean-Luc ;
Guillarme, Davy .
ANALYTICAL CHEMISTRY, 2019, 91 (01) :210-239
[6]   The transfer of analytical procedures [J].
Ermer, J. ;
Limberger, M. ;
Lis, K. ;
Waetzig, H. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 85 :262-276
[7]   Rapid Development of a Commercial Process for Linrodostat, an Indoleamine 2,3-Dioxygenase (IDO) Inhibitor [J].
Fraunhoffer, Kenneth J. ;
DelMonte, Albert J. ;
Beutner, Gregory L. ;
Bultman, Michael S. ;
Camacho, Kathryn ;
Cohen, Benjamin ;
Dixon, Darryl D. ;
Fan, Yu ;
Fanfair, Dayne ;
Freitag, Adam J. ;
Glace, Andrew W. ;
Gonzalez-Bobes, Francisco ;
Gujjar, Manjunath ;
Haley, Matthew W. ;
Hickey, Matthew R. ;
Ho, Jeanne ;
Iyer, Vidya ;
Maity, Prantik ;
Patel, Sunil ;
Rosso, Victor W. ;
Schmidt, Michael A. ;
Stevens, Jason M. ;
Tan, Yichen ;
Wilbert, Christopher ;
Young, Ian S. ;
Yu, Miao .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2019, 23 (11) :2482-2498
[8]  
International Conference on Harmonization (ICH) Guidelines Q3A (R2), 2006, INT C HARMONIZATION
[9]   Repeatability and reproducibility of retention data and band profiles on reversed-phase liquid chromatography columns III.: Results obtained with Kromasil C18 columns [J].
Kele, M ;
Guiochon, G .
JOURNAL OF CHROMATOGRAPHY A, 1999, 855 (02) :423-453
[10]   Repeatability and reproducibility of retention data and band profiles on reversed-phase liquid chromatography columns -: IV.: Results obtained with luna C18 (2) columns [J].
Kele, M ;
Guiochon, G .
JOURNAL OF CHROMATOGRAPHY A, 2000, 869 (1-2) :181-209